Abstract Background The Infectious Diseases Society of America is committed to providing
up-to-date guidance on the treatment of antimicrobial-resistant infections. This guidance …

Antibacterial resistance is a renewed public health plague in modern times, and the COVID-
19 pandemic has rekindled this problem. Changes in antibiotic prescribing behavior …

A nosocomial outbreak by cefiderocol (FDC)-resistant NDM-1-producing Klebsiella
pneumoniae (NDM-Kp) occurred in a large tertiary care hospital from August 2021–June …

Due to the fact that there is a steadily increasing trend in the area of antimicrobial resistance
in microorganisms, there is a need to look for new treatment alternatives. One of them is the …

Antimicrobials (eg, antibiotics and biocides) are invaluable chemicals used to control
microbes in numerous contexts. Because of the simultaneous use of antibiotics and …

Abstract Objectives Carbapenemase-producing Enterobacterales represent a major cause
of difficult-to-treat infections world-wide. Novel β-lactam/β-lactamase inhibitor combinations …

Antimicrobial resistance is a global health threat. Among Gram-negative bacteria, resistance
to carbapenems, a class of β-lactam antibiotics, is usually a proxy for difficult-to-treat …

Objectives To investigate a ceftazidime/avibactam (CZA)-resistant Klebsiella pneumoniae
(NE368), isolated from a patient exposed to CZA, expressing a novel K. pneumoniae …

The emergence and transmission of antibiotic resistance is a global public health crisis with
significant burden on healthcare systems, resulting in high mortality and economic costs. In …

ABSTRACT Klebsiella pneumoniae carbapenemase-2 (KPC-2) presents a clinical threat as
this β-lactamase confers resistance to carbapenems. Recent variants of KPC-2 in clinical …